{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Q",
          "alt": "P",
          "position": "126"
        },
        "variant_string_id": "PINK1 Q126P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mitochondrial dysfunction is an early sign of many neurodegenerative diseases...two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy).",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as mitochondrial dysfunction leading to neurodegeneration, with PINK1 and Parkin playing a role in mitophagy."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 kinase activity is needed for prompt and efficient Parkin recruitment to impaired mitochondria...Here we show that disease-associated PINK1 mutations also compromise the selective degradation of depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assay measures the effect of PINK1 mutations on Parkin translocation and mitophagy, which are directly related to the defined disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HeLa cells were transiently transfected with a specific PINKI siRNA, resulting in efficient knockdown of FL and cleaved forms of endogenous PINK1 (Fig. 1A). A scrambled siRNA was used as a negative control...cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls...Expression of PINK1-V5 WT or mutant variants resulted in comparable PINK1 protein levels (Fig. 1B).",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both negative controls (scrambled siRNA, empty vector) and positive controls (PINK1-V5 WT). Multiple replicates were implied through descriptions of multiple experiments and quantification of results.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "The study uses known PD-associated variants as experimental conditions, not as positive or negative controls with a well-established pathogenicity, therefore not meeting this criterion.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantification of (D) Parkin co-localization with impaired mitochondria after 2 h and (F) remaining mitochondria after 24 h CCCP treatment in Parkin- and PINK1-positive cells. Scored were ≥200 Parkin-positive cells in at least three independent experiments...Asterisk(s) indicate significance compared to control siRNA: *p < 0.05, **p < 0.005, ***p < 0.0005.",
          "judgment": "No",
          "reasoning": "Statistical significance is indicated, but the study does not provide an OddsPath calculation or sufficient statistical data to reliably infer OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "A limited number of variant controls tested were less than 10",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 Q126P mutation compromises Parkin translocation to mitochondria. Given the overall experimental setup and statistical analyses, the strength of evidence is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mitochondrial dysfunction is an early sign of many neurodegenerative diseases...two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy).",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as mitochondrial dysfunction leading to neurodegeneration, with PINK1 and Parkin playing a role in mitophagy."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 kinase activity is needed for prompt and efficient Parkin recruitment to impaired mitochondria...Here we show that disease-associated PINK1 mutations also compromise the selective degradation of depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assay measures the effect of PINK1 mutations on Parkin translocation and mitophagy, which are directly related to the defined disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HeLa cells were transiently transfected with a specific PINKI siRNA, resulting in efficient knockdown of FL and cleaved forms of endogenous PINK1 (Fig. 1A). A scrambled siRNA was used as a negative control...cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls...Expression of PINK1-V5 WT or mutant variants resulted in comparable PINK1 protein levels (Fig. 1B).",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both negative controls (scrambled siRNA, empty vector) and positive controls (PINK1-V5 WT). Multiple replicates were implied through descriptions of multiple experiments and quantification of results.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "The study uses known PD-associated variants as experimental conditions, not as positive or negative controls with a well-established pathogenicity, therefore not meeting this criterion.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantification of (D) Parkin co-localization with impaired mitochondria after 2 h and (F) remaining mitochondria after 24 h CCCP treatment in Parkin- and PINK1-positive cells. Scored were ≥200 Parkin-positive cells in at least three independent experiments...Asterisk(s) indicate significance compared to control siRNA: *p < 0.05, **p < 0.005, ***p < 0.0005.",
          "judgment": "No",
          "reasoning": "Statistical significance is indicated, but the study does not provide an OddsPath calculation or sufficient statistical data to reliably infer OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "A limited number of variant controls tested were less than 10",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 L347P mutation compromises Parkin translocation to mitochondria. Given the overall experimental setup and statistical analyses, the strength of evidence is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mitochondrial dysfunction is an early sign of many neurodegenerative diseases...two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy).",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as mitochondrial dysfunction leading to neurodegeneration, with PINK1 and Parkin playing a role in mitophagy."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 kinase activity is needed for prompt and efficient Parkin recruitment to impaired mitochondria...Here we show that disease-associated PINK1 mutations also compromise the selective degradation of depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "The assay measures the effect of PINK1 mutations on Parkin translocation and mitophagy, which are directly related to the defined disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HeLa cells were transiently transfected with a specific PINKI siRNA, resulting in efficient knockdown of FL and cleaved forms of endogenous PINK1 (Fig. 1A). A scrambled siRNA was used as a negative control...cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls...Expression of PINK1-V5 WT or mutant variants resulted in comparable PINK1 protein levels (Fig. 1B).",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of both negative controls (scrambled siRNA, empty vector) and positive controls (PINK1-V5 WT). Multiple replicates were implied through descriptions of multiple experiments and quantification of results.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "The study uses known PD-associated variants as experimental conditions, not as positive or negative controls with a well-established pathogenicity, therefore not meeting this criterion.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Quantification of (D) Parkin co-localization with impaired mitochondria after 2 h and (F) remaining mitochondria after 24 h CCCP treatment in Parkin- and PINK1-positive cells. Scored were ≥200 Parkin-positive cells in at least three independent experiments...Asterisk(s) indicate significance compared to control siRNA: *p < 0.05, **p < 0.005, ***p < 0.0005.",
          "judgment": "No",
          "reasoning": "Statistical significance is indicated, but the study does not provide an OddsPath calculation or sufficient statistical data to reliably infer OddsPath.",
          "next_step_or_outcome": "Proceed to Sub-step 4b."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "cells were double transfected with EGFP-Parkin WT along with PINK1-V5 WT, PD-linked mutants Q126P, L347P and W437X or artificial variants that lack kinase activity (3xKD) or the first 111 amino acids (AMTS) as controls",
          "judgment": "No",
          "reasoning": "A limited number of variant controls tested were less than 10",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 W437X mutation compromises Parkin translocation to mitochondria. Given the overall experimental setup and statistical analyses, the strength of evidence is PS3_supporting."
    }
  ]
}
